|
Real-time Estimate
Cboe BZX
23:01:55 29/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 59.76 USD | -0.75% |
|
+2.59% | -9.82% |
| Market Cap | 8.5B 7.62B 7.03B 6.36B 11.89B 810B 12.08B 83.85B 33.45B 424B 31.92B 31.24B 1,342B | P/E 2026 * |
-16.7x | P/E 2027 * | -12.8x |
|---|---|---|---|---|---|
| Enterprise Value | 7.67B 6.87B 6.34B 5.74B 10.73B 731B 10.9B 75.64B 30.18B 382B 28.79B 28.18B 1,211B | EV / Sales 2026 * |
16.5x | EV / Sales 2027 * | 23.8x |
| Free-Float |
94.56% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| ARWR | Delayed | |
CBOE
| ARWR | Real-time | |
|
Berne S.E.
| HDP1 | End-of-day quote | |
|
Tradegate
| HDP1 | Real-time | |
|
Xetra
| HDP1 | Delayed | |
|
London S.E.
| 0HI3 | Delayed | |
|
Boerse Muenchen
| HDP1 | Real-time | |
|
Deutsche Boerse AG
| HDP1 | Delayed | |
|
Börse Stuttgart
| HDP1 | Delayed |
Last Transcript: Arrowhead Pharmaceuticals, Inc.
| 1 day | -0.66% | ||
| 1 week | +2.59% | ||
| Current month | -8.53% | ||
| 1 month | -9.63% | ||
| 3 months | -30.56% | ||
| 6 months | -15.11% | ||
| Current year | -9.82% |
| 1 week | 56.56 |  | 61.88 |
| 1 month | 55.83 | | 66.8 |
| Current year | 54.02 | | 95.49 |
| 1 year | 37.06 | | 95.49 |
| 3 years | 9.57 | | 95.49 |
| 5 years | 9.57 | | 95.49 |
| 10 years | 1.2 | | 95.49 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 56 | 01/12/2007 | |
Daniel Apel
DFI | Director of Finance/CFO | - | 13/05/2025 |
Peter Carignan
CTO | Chief Tech/Sci/R&D Officer | - | 01/08/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 56 | - | |
Mauro Ferrari
BRD | Director/Board Member | 66 | 19/08/2010 |
Michael Perry
BRD | Director/Board Member | 66 | 19/12/2011 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 18/08/26 | Sell | Director | -2,000 | 0.0014% | ||
| 18/08/26 | Sell | Director | -11,600 | 0.0082% | ||
| 15/06/26 | Free | Director | 11,882 | 0.0084% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.75% | +2.59% | +48.60% | +157.84% | 8.5B | |
| +0.34% | -3.03% | +37.45% | +61.06% | 64.14B | |
| +0.98% | +2.68% | +12.25% | +83.90% | 55.53B | |
| +1.75% | +2.01% | +13.30% | +105.71% | 53.03B | |
| -1.79% | -1.55% | +25.78% | +54.66% | 45.99B | |
| -1.18% | -3.50% | +17.17% | +97.69% | 42.45B | |
| -0.40% | +0.30% | +224.47% | +925.94% | 40.45B | |
| -0.26% | -4.20% | +10.86% | +45.18% | 32.25B | |
| -2.07% | +42.73% | +103.77% | +90.26% | 34.47B | |
| -2.72% | -8.79% | +22.58% | -5.63% | 24.23B | |
| Average | -0.62% | +3.67% | +51.62% | +161.66% | 40.1B | |
| Weighted average by Cap. | -0.35% | +3.11% | +49.05% | +159.76% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 464M 416M 384M 347M 649M 44.2B 659M 4.58B 1.83B 23.13B 1.74B 1.7B 73.26B | 328M 294M 271M 245M 459M 31.26B 466M 3.24B 1.29B 16.36B 1.23B 1.21B 51.81B |
| Net income | -513M -459M -424M -383M -717M -48.82B -728M -5.05B -2.02B -25.55B -1.92B -1.88B -80.92B | -663M -594M -548M -496M -927M -63.16B -942M -6.54B -2.61B -33.05B -2.49B -2.44B -105B |
| Net Debt | -832M -746M -688M -622M -1.16B -79.26B -1.18B -8.21B -3.27B -41.48B -3.12B -3.06B -131B | -683M -612M -564M -511M -955M -65.02B -970M -6.73B -2.69B -34.03B -2.56B -2.51B -108B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 29/10/26 | $59.93 | -0.47% | 734,264 |
| 28/10/26 | $60.21 | +2.00% | 1,248,403 |
| 27/10/26 | $59.03 | +0.08% | 2,118,861 |
| 26/10/26 | $58.98 | +1.65% | 979,892 |
| 23/10/26 | $58.02 | -0.58% | 871,820 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ARWR Stock
Select your edition
All financial news and data tailored to specific country editions
